Sanara MedTech Share Holder Equity 2014-2025 | SMTI
Sanara MedTech share holder equity from 2014 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
| Sanara MedTech Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2024 | $39 |
| 2023 | $45 |
| 2022 | $42 |
| 2021 | $30 |
| 2020 | $6 |
| 2019 | $6 |
| 2018 | $1 |
| 2017 | $0 |
| 2016 | $0 |
| 2015 | $-1 |
| 2014 | $-1 |
| 2013 | $-2 |
| Sanara MedTech Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2025-03-31 | $37 |
| 2024-12-31 | $39 |
| 2024-09-30 | $39 |
| 2024-06-30 | $41 |
| 2024-03-31 | $43 |
| 2023-12-31 | $45 |
| 2023-09-30 | $44 |
| 2023-06-30 | $41 |
| 2023-03-31 | $41 |
| 2022-12-31 | $42 |
| 2022-09-30 | $45 |
| 2022-06-30 | $35 |
| 2022-03-31 | $29 |
| 2021-12-31 | $30 |
| 2021-09-30 | $33 |
| 2021-06-30 | $35 |
| 2021-03-31 | $35 |
| 2020-12-31 | $6 |
| 2020-09-30 | $6 |
| 2020-06-30 | $6 |
| 2020-03-31 | $7 |
| 2019-12-31 | $6 |
| 2019-09-30 | $-2 |
| 2019-06-30 | $-1 |
| 2019-03-31 | $-1 |
| 2018-12-31 | $1 |
| 2018-09-30 | $2 |
| 2018-06-30 | $2 |
| 2018-03-31 | $2 |
| 2017-12-31 | $0 |
| 2017-09-30 | $0 |
| 2017-06-30 | $0 |
| 2017-03-31 | $0 |
| 2016-12-31 | $0 |
| 2016-09-30 | |
| 2016-06-30 | |
| 2016-03-31 | |
| 2015-12-31 | $-1 |
| 2015-09-30 | |
| 2015-06-30 | |
| 2015-03-31 | |
| 2014-12-31 | $-1 |
| 2014-09-30 | |
| 2014-06-30 | |
| 2014-03-31 | |
| 2013-12-31 | $-2 |
| 2013-09-30 | |
| 2013-06-30 | |
| 2013-03-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.222B | $0.087B |
| Wound Management Technologies Inc. develops and markets wound care products. It develops, markets and distributes biotechnology products to physicians, hospitals and clinics. The Company markets collagen-based products for the treatment of pressure ulcers, diabetic ulcers, surgical wounds, ulcers due to arterial insufficiency, traumatic wounds, first and second degree burns and superficial wounds. It sells and distributes CellerateRX(R) Surgical Activated Collagen(R) Adjuvant as well as HemaQuell(R) Resorbable Bone Hemostat. Wound Management Technologies Inc. is based in Fort Worth, Texas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $219.828B | 25.79 |
| Boston Scientific (BSX) | United States | $156.585B | 37.40 |
| Stryker (SYK) | United States | $152.939B | 31.98 |
| EssilorLuxottica (ESLOY) | France | $137.925B | 0.00 |
| Medtronic (MDT) | Ireland | $117.956B | 16.72 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.343B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.576B | 24.87 |
| ResMed (RMD) | United States | $40.103B | 30.12 |
| GE HealthCare Technologies (GEHC) | United States | $35.596B | 16.90 |
| Agilent Technologies (A) | United States | $33.957B | 22.14 |
| Terumo (TRUMY) | Japan | $25.643B | 33.31 |
| Koninklijke Philips (PHG) | Netherlands | $24.709B | 17.34 |
| Insulet (PODD) | United States | $20.568B | 80.74 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.989B | 12.20 |
| Baxter (BAX) | United States | $14.636B | 10.93 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.656B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.891B | 23.98 |
| Lantheus Holdings (LNTH) | United States | $5.010B | 12.64 |
| Perrigo (PRGO) | Ireland | $3.867B | 9.80 |
| Prestige Consumer Healthcare (PBH) | United States | $3.770B | 16.84 |
| Haemonetics (HAE) | United States | $3.587B | 16.34 |
| Envista Holdings (NVST) | United States | $3.515B | 29.21 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.138B | 23.14 |
| LeMaitre Vascular (LMAT) | United States | $1.863B | 41.65 |
| QuidelOrtho (QDEL) | United States | $1.764B | 12.14 |
| AtriCure (ATRC) | United States | $1.645B | 0.00 |
| Acuren (TIC) | United States | $1.367B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.332B | 29.96 |
| AdaptHealth (AHCO) | United States | $1.294B | 13.14 |
| Neogen (NEOG) | United States | $1.176B | 15.06 |
| Phibro Animal Health (PAHC) | United States | $1.172B | 14.98 |
| BioLife Solutions (BLFS) | United States | $1.063B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.987B | 0.00 |
| InMode (INMD) | Israel | $0.919B | 9.26 |
| Kestra Medical Technologies (KMTS) | United States | $0.847B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.704B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.675B | 0.00 |
| Valneva SE (VALN) | France | $0.648B | 0.00 |
| Owens & Minor (OMI) | United States | $0.608B | 5.04 |
| Evolus (EOLS) | United States | $0.598B | 0.00 |
| CeriBell (CBLL) | United States | $0.541B | 0.00 |
| Surmodics (SRDX) | United States | $0.524B | 0.00 |
| ZimVie (ZIMV) | United States | $0.524B | 23.82 |
| SNDL (SNDL) | Canada | $0.394B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.358B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.329B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.325B | 11.97 |
| Quanterix (QTRX) | United States | $0.324B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.310B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.306B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.269B | 79.67 |
| Cerus (CERS) | United States | $0.260B | 0.00 |
| Omeros (OMER) | United States | $0.256B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.251B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.246B | 20.77 |
| Biote (BTMD) | United States | $0.239B | 6.72 |
| Verano Holdings (VRNOF) | United States | $0.238B | 0.00 |
| Brainsway (BWAY) | Israel | $0.227B | 60.00 |
| Canopy Growth (CGC) | Canada | $0.224B | 0.00 |
| Organigram Global (OGI) | Canada | $0.198B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.188B | 15.45 |
| High Tide (HITI) | Canada | $0.184B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.172B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.170B | 0.00 |
| Exagen (XGN) | United States | $0.157B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.138B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.120B | 14.83 |
| MacroGenics (MGNX) | United States | $0.105B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.104B | 0.00 |
| Jin Medical (ZJYL) | China | $0.104B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 12.77 |
| Quipt Home Medical (QIPT) | United States | $0.093B | 0.00 |
| Apyx Medical (APYX) | United States | $0.091B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.090B | 0.00 |
| Safety Shot (SHOT) | United States | $0.088B | 0.00 |
| Zynex (ZYXI) | United States | $0.077B | 0.00 |
| Veru (VERU) | United States | $0.077B | 0.00 |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| Agape ATP (ATPC) | $0.067B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.059B | 0.00 |
| United-Guardian (UG) | United States | $0.039B | 13.38 |
| Nephros (NEPH) | United States | $0.038B | 51.43 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.022B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.012B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |